CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial

BACKGROUND: Worldwide, over 10 million people are killed or hospitalized because of traumatic brain injury each year. About 90% of deaths occur in low- and middle-income countries. The condition mostly affects young adults, and many experience long lasting or permanent disability. The social and eco...

Descripción completa

Detalles Bibliográficos
Autores principales: Dewan, Yashbir, Komolafe, Edward O, Mejía-Mantilla, Jorge H, Perel, Pablo, Roberts, Ian, Shakur, Haleema
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481366/
https://www.ncbi.nlm.nih.gov/pubmed/22721545
http://dx.doi.org/10.1186/1745-6215-13-87

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481366/
https://www.ncbi.nlm.nih.gov/pubmed/22721545
http://dx.doi.org/10.1186/1745-6215-13-87

Ejemplares similares